This whitepaper updates CRDSA’s 2022 systematic review of data contributor policies and data protection methodologies. This update includes information published by 35 biopharma sponsors. Highlights include:
- The review now covers 35 biopharma sponsors, a 20% increase from 2022.
- The consistency of dataset- and documentation-sharing policy commitments establish a reference benchmark for all data contributing organizations.
- Challenges remain in the areas of data transformation transparency and data protection methodology.